CD28 and hepatocellular carcinoma: To investigate the impact of tumorous SQLE on CD8+ T cells, we first constructed SQLE HCC cell lines (online supplemental figure 2A,B), and co-cultured them with human peripheral blood-derived CD8+ T cells, which were simultaneously stimulated with anti-CD3/CD28.